GLS2 and glioblastoma: Through increasing GLS2 expression, p53 is also able to increase de novo GSH production and maintain GSH/GSSG (GSH disulphide) ratios in response to oxidative stress in glioblastoma cells by increasing GSH pre-cursors (Hu et al., 2010; Suzuki et al., 2010).